Form 4: Intuitive Surgical Exec's Routine Equity Transactions

Intuitive Surgical's EVP & Chief Legal and Compliance Officer, Gary Loeb, reported routine equity transactions including RSU vesting, PSU achievement, and tax-related share dispositions.

Summary

• Gary Loeb, EVP & Chief Legal and Compliance Officer of Intuitive Surgical Inc. (ISRG), reported changes in his beneficial ownership of company stock.
• On February 26, 2026, Loeb acquired 1,526 shares of common stock through the vesting of Restricted Stock Units (RSUs) at an exercise price of $0.0.
• Concurrently, 757 shares were disposed of at a price of $506.17 to cover statutory tax withholding requirements related to the RSU vesting.
• An additional 916 shares of common stock were acquired on February 26, 2026, also from RSU vesting at an exercise price of $0.0.
• 455 shares were disposed of at $506.17 on the same date to cover statutory tax withholding for this RSU vesting.
• Performance Stock Units (PSUs) granted on February 28, 2023, with performance criteria achieved, resulted in the acquisition of 1,050 underlying common stock units, vesting on February 28, 2026.
• New Restricted Stock Units (RSUs) representing 3,584 contingent rights to receive common stock were acquired on February 26, 2026, with vesting scheduled 25% annually over four years.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing standard executive compensation activities and not indicative of new strategic direction or significant operational changes.

Positives

• Performance criteria for Performance Stock Units (PSUs) granted on February 28, 2023, have been achieved, leading to their vesting.
• Routine vesting of Restricted Stock Units (RSUs) indicates the fulfillment of executive compensation plans.

Future Outlook

Performance Stock Units (PSUs) granted on February 28, 2023, are scheduled to fully vest on February 28, 2026, contingent on the Reporting Person's continuous service. New Restricted Stock Units (RSUs) granted on February 26, 2026, will vest 25% annually over a four-year period.

Industry Context

StockSavvy.ai notes these are routine insider transactions related to executive compensation, common across publicly traded companies, and reflect the vesting schedule of equity awards. Such filings provide transparency into executive stock ownership but typically do not signal changes in company strategy or performance.

Comparison to Industry Standards

• These types of transactions, involving the vesting of Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) followed by dispositions for tax withholding, are standard practice for executive compensation in the medical device and technology sectors.
• This aligns with typical equity incentive plans observed at peer companies such as Medtronic (MDT) or Stryker Corporation (SYK), where executive compensation often includes a significant equity component tied to performance and tenure.

Stakeholder Impact

• Shareholders: The transactions represent routine executive compensation and do not indicate a material change in company fundamentals or strategy. The impact on overall share float is minimal.
• Employees: The vesting and granting of equity awards are standard components of executive compensation, aligning with broader company incentive structures.

Next Steps

• Future vesting of the remaining tranches of Restricted Stock Units (RSUs) granted on February 26, 2026, will occur annually over the next four years.

Key Dates

Recommendation

This Form 4 filing details routine equity transactions for an executive, primarily related to the vesting of restricted stock units and performance stock units, along with associated tax withholdings. Such transactions are part of standard executive compensation and do not provide new fundamental information to warrant a change in investment recommendation. The company's underlying business performance and strategic outlook remain the primary drivers for investment decisions.

Keywords

Intuitive Surgical, ISRG, Form 4, Insider Transaction, Executive Compensation, Restricted Stock Units, Performance Stock Units, Equity Vesting, Tax Withholding